Go Pro

BioVie (BIVI) News Today

BioVie logo
$2.00 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

BioVie Latest News

BioVie (NASDAQ:BIVI) Raised to "Hold" at Wall Street Zen
BioVie Inc. (NASDAQ:BIVI) Short Interest Up 56.7% in August
BioVie completes final patient visit in Phase 2 Long COVID trial
Why BioVie (BIVI) Stock Is Up Today
Parkinson's drug developers are betting big on inflammation
BioVie Inc. Class A
BioVie: Long COVID trial fully enrolled – ICYMI
BioVie: Long COVID trial fully enrolled – ICYMI
BioVie completes enrollment in Phase 2 Long COVID trial
BioVie CEO shares insights into long COVID trial - ICYMI
BioVie CEO explains Bezisterim Parkinson's trial results - ICYMI
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
BioVie highlights bezisterim research at ACP meeting
BioVie could offer first new Parkinson’s therapy in decades

BioVie Media Mentions By Week

BioVie Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIVI
News Sentiment

0.25

0.78

Average
Healthcare
News Sentiment

BioVie News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIVI Articles
This Week

4

2

BIVI Articles
Average Week

BioVie Trends on MarketBeat

This week vs. last week
Searches
2
-33%
Page Views
2,295
+9%
Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for BioVie dated 8/31/2026.
From Our Partners